Process View
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "fibroblast growth factor receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FGFR2 | fibroblast growth factor receptor 2 | 1.000 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.999 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.997 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.996 | ||
| STAMBP | STAM binding protein | 0.859 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.851 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.700 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.571 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.549 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.539 | ||
| FGF10 | fibroblast growth factor 10 | 0.509 | ||
| SH2D1A | SH2 domain containing 1A | 0.485 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.436 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.432 | ||
| ZUFSP | zinc finger with UFM1-specific peptidase domain | 0.427 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.391 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.367 | Mouse | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.290 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.285 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.272 | ||
| HDAC7 | histone deacetylase 7 | 0.243 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.239 | ||
| TESK1 | testis-specific kinase 1 | 0.155 | ||
| CTGF | connective tissue growth factor | 0.149 | Mouse | |
| SPRY2 | sprouty homolog 2 (Drosophila) | 0.142 | Mouse Fly | |
| TGFB1 | transforming growth factor, beta 1 | 0.141 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.136 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.135 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.135 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.120 | ||
| HIC1 | hypermethylated in cancer 1 | 0.120 | ||
| EGFR | epidermal growth factor receptor | 0.119 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.118 | ||
| FN1 | fibronectin 1 | 0.114 | ||
| EEA1 | early endosome antigen 1 | 0.105 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.097 | ||
| FGF7 | fibroblast growth factor 7 | 0.095 | ||
| STMN2 | stathmin-like 2 | 0.093 | ||
| LIN28B | lin-28 homolog B (C. elegans) | 0.081 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.080 | ||
| APC | adenomatous polyposis coli | 0.080 | ||
| SNRNP70 | small nuclear ribonucleoprotein 70kDa (U1) | 0.079 | ||
| JAK1 | Janus kinase 1 | 0.073 | ||
| FERMT2 | fermitin family member 2 | 0.068 | ||
| ATF2 | activating transcription factor 2 | 0.066 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.064 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.064 | ||
| TSG101 | tumor susceptibility gene 101 | 0.064 | ||
| MARCKS | myristoylated alanine-rich protein kinase C substrate | 0.062 | ||
| KLB | klotho beta | 0.060 | ||
| ERBB2IP | erbb2 interacting protein | 0.055 | ||
| ABI1 | abl-interactor 1 | 0.055 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.051 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.050 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.049 | ||
| NCK1 | NCK adaptor protein 1 | 0.049 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.047 | Fly | |
| GAB2 | GRB2-associated binding protein 2 | 0.047 | ||
| PDGFC | platelet derived growth factor C | 0.046 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.042 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.041 | ||
| AP1G1 | adaptor-related protein complex 1, gamma 1 subunit | 0.041 | ||
| LAT | linker for activation of T cells | 0.041 | ||
| HGS | hepatocyte growth factor-regulated tyrosine kinase substrate | 0.039 | Fly | |
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.039 | ||
| THBS1 | thrombospondin 1 | 0.038 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.038 | ||
| BMP7 | bone morphogenetic protein 7 | 0.035 | ||
| FBLN1 | fibulin 1 | 0.035 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.034 | ||
| VCAN | versican | 0.034 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.034 | ||
| SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0.034 | Mouse Fly | |
| NRP1 | neuropilin 1 | 0.034 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.033 | ||
| EGR1 | early growth response 1 | 0.033 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.033 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.032 | ||
| ACTN4 | actinin, alpha 4 | 0.031 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.030 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.030 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.030 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.030 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.029 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.029 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.029 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.028 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.027 | ||
| CAPZA2 | capping protein (actin filament) muscle Z-line, alpha 2 | 0.027 | ||
| CD33 | CD33 molecule | 0.026 | ||
| EPS15 | epidermal growth factor receptor pathway substrate 15 | 0.026 | ||
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 0.026 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.026 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.025 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.025 | ||
| RCC1 | regulator of chromosome condensation 1 | 0.025 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.024 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.024 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.024 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.024 | ||
| SDC2 | syndecan 2 | 0.024 | ||
| BMP2 | bone morphogenetic protein 2 | 0.024 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.024 | ||
| PSEN1 | presenilin 1 | 0.023 | ||
| RET | ret proto-oncogene | 0.023 | ||
| JAK2 | Janus kinase 2 | 0.023 | ||
| MDFI | MyoD family inhibitor | 0.023 | ||
| ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | 0.022 | ||
| CD2AP | CD2-associated protein | 0.021 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.021 | ||
| FGF19 | fibroblast growth factor 19 | 0.021 | ||
| CTSB | cathepsin B | 0.020 | ||
| EGR3 | early growth response 3 | 0.020 | ||
| HAS2 | hyaluronan synthase 2 | 0.019 | ||
| RRBP1 | ribosome binding protein 1 homolog 180kDa (dog) | 0.019 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.019 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.019 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.019 | ||
| FSTL1 | follistatin-like 1 | 0.018 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.018 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.018 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.018 | ||
| GORASP1 | golgi reassembly stacking protein 1, 65kDa | 0.017 | ||
| EPOR | erythropoietin receptor | 0.017 | ||
| BTRC | beta-transducin repeat containing | 0.017 | ||
| EGR2 | early growth response 2 | 0.017 | ||
| IL4R | interleukin 4 receptor | 0.017 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.016 | ||
| ENG | endoglin | 0.016 | ||
| BGN | biglycan | 0.016 | ||
| FBXL5 | F-box and leucine-rich repeat protein 5 | 0.016 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.016 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.016 | ||
| SMC6 | structural maintenance of chromosomes 6 | 0.016 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.016 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.016 | ||
| PRDM8 | PR domain containing 8 | 0.016 | ||
| TNPO1 | transportin 1 | 0.015 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.015 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.015 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.015 | ||
| ETV5 | ets variant 5 | 0.015 | ||
| COIL | coilin | 0.015 | ||
| THBS2 | thrombospondin 2 | 0.015 | Human | |
| PKP4 | plakophilin 4 | 0.015 | ||
| FGF4 | fibroblast growth factor 4 | 0.015 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.015 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.015 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.015 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.014 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.014 | ||
| NOTCH3 | notch 3 | 0.014 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.014 | ||
| EXOC7 | exocyst complex component 7 | 0.014 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.014 | ||
| FGF3 | fibroblast growth factor 3 | 0.014 | ||
| TRIP12 | thyroid hormone receptor interactor 12 | 0.014 | ||
| MT2A | metallothionein 2A | 0.014 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.014 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.013 | ||
| SMAD3 | SMAD family member 3 | 0.013 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.013 | ||
| SFN | stratifin | 0.013 | ||
| PICALM | phosphatidylinositol binding clathrin assembly protein | 0.013 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.013 | ||
| INHBA | inhibin, beta A | 0.013 | ||
| MPZL1 | myelin protein zero-like 1 | 0.013 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.013 | ||
| FBLN2 | fibulin 2 | 0.013 | ||
| VEGFA | vascular endothelial growth factor A | 0.013 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.012 | ||
| SLC9A6 | solute carrier family 9 (sodium/hydrogen exchanger), member 6 | 0.012 | ||
| SLK | STE20-like kinase | 0.012 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.012 | ||
| SCARB2 | scavenger receptor class B, member 2 | 0.012 | ||
| SIRPA | signal-regulatory protein alpha | 0.012 | ||
| A2M | alpha-2-macroglobulin | 0.012 | ||
| NTM | neurotrimin | 0.012 | ||
| ITGB3BP | integrin beta 3 binding protein (beta3-endonexin) | 0.012 | ||
| THY1 | Thy-1 cell surface antigen | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.012 | ||
| DCN | decorin | 0.011 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.011 | ||
| RIN2 | Ras and Rab interactor 2 | 0.011 | ||
| KRT8 | keratin 8 | 0.011 | ||
| TNC | tenascin C | 0.011 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.011 | ||
| C9orf25 | chromosome 9 open reading frame 25 | 0.011 | ||
| CDH7 | cadherin 7, type 2 | 0.011 | ||
| XPOT | exportin, tRNA (nuclear export receptor for tRNAs) | 0.011 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.011 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.011 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.011 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.011 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.011 | ||
| PJA2 | praja ring finger 2 | 0.011 | ||
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.011 | ||
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.011 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.011 | ||
| KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 0.011 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.011 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.010 | ||
| VEGFC | vascular endothelial growth factor C | 0.010 | ||
| PLXDC1 | plexin domain containing 1 | 0.010 | ||
| MTPN | myotrophin | 0.010 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.010 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.010 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.010 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.010 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.010 | ||
| COMP | cartilage oligomeric matrix protein | 0.010 | Human | |
| SGMS1 | sphingomyelin synthase 1 | 0.010 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.010 | ||
| EMP1 | epithelial membrane protein 1 | 0.010 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.010 |